Viewing Study NCT05506332


Ignite Creation Date: 2025-12-24 @ 9:41 PM
Ignite Modification Date: 2026-01-01 @ 5:49 PM
Study NCT ID: NCT05506332
Status: RECRUITING
Last Update Posted: 2022-08-18
First Post: 2022-08-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment With ABT-199 (Venetoclax) and Purine Analogues in Relapsed/Refractory Acute Myeloid Leukemia
Sponsor: University Hospital, Antwerp
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module